112 related articles for article (PubMed ID: 3996806)
1. Orphan Drugs Information Center.
FDA Drug Bull; 1985 Apr; 15(1):9-10. PubMed ID: 3996806
[No Abstract] [Full Text] [Related]
2. Academic center approaches to orphan drug research and development.
Hauck FP; Chung EY; Van Woert MH
Prog Clin Biol Res; 1985; 197():115-22. PubMed ID: 4070286
[No Abstract] [Full Text] [Related]
3. [Orphan drugs: some legal, ethical and economics aspects].
Pabst JY
Rev Epidemiol Sante Publique; 2001 Sep; 49(4):387-96. PubMed ID: 11567205
[TBL] [Abstract][Full Text] [Related]
4. Orphan Drug Act on congressional agenda.
von Oehsen WH
Physician Exec; 1989; 15(3):34-5. PubMed ID: 10313123
[TBL] [Abstract][Full Text] [Related]
5. Orphan drug development in the United States.
Groft SC
CPJ; 1985 May; 118(5):219-22. PubMed ID: 10271306
[TBL] [Abstract][Full Text] [Related]
6. The fuel to run the orphan drug engine: a medical school-based Orphan Disease Center Program.
Brewer GJ
Prog Clin Biol Res; 1985; 197():123-38. PubMed ID: 4070287
[No Abstract] [Full Text] [Related]
7. The development of orphan drugs--a pharmaceutical company perspective.
Stucki JC
Prog Clin Biol Res; 1985; 197():95-104. PubMed ID: 4070303
[No Abstract] [Full Text] [Related]
8. Problems associated with developing orphan drugs into available therapy.
Van Woert MH
Prog Clin Biol Res; 1985; 197():171-3. PubMed ID: 4070291
[No Abstract] [Full Text] [Related]
9. National Orphan Drugs and Devices Foundation.
Bennett J
Prog Clin Biol Res; 1985; 197():47-9. PubMed ID: 4070299
[No Abstract] [Full Text] [Related]
10. Orphan drugs. Improved medical treatment of rare diseases.
Cramer R
Ala J Med Sci; 1988 Jul; 25(3):257-67. PubMed ID: 3052135
[No Abstract] [Full Text] [Related]
11. Cooperative approaches to research and development of orphan drugs. Proceedings of a conference. New York, New York, April 9 and 10, 1984.
Prog Clin Biol Res; 1985; 197():1-204. PubMed ID: 4070283
[No Abstract] [Full Text] [Related]
12. CMS move threatens to put orphan drugs out in cold.
Carroll J
Manag Care; 2003 Jul; 12(7):10-1. PubMed ID: 12891947
[No Abstract] [Full Text] [Related]
13. [Orphan drugs].
Kolár J; Chalabala M; Srámková H
Ceska Slov Farm; 2001 Mar; 50(2):59-65. PubMed ID: 11288591
[TBL] [Abstract][Full Text] [Related]
14. The role of voluntary disease organizations in research and development of orphan drugs.
Horansky R
Prog Clin Biol Res; 1985; 197():179-81. PubMed ID: 4070293
[No Abstract] [Full Text] [Related]
15. Generic Pharmaceutical Industry Association Orphan Drug Institute.
Haddad W
Prog Clin Biol Res; 1985; 197():41-5. PubMed ID: 4070298
[No Abstract] [Full Text] [Related]
16. 1989 annual survey--133 orphan drug products.
Hosp Pharm; 1990 Apr; 25(4):367-71, 375-86. PubMed ID: 10104391
[No Abstract] [Full Text] [Related]
17. The Pharmaceutical Manufacturers Association Commission on Drugs for Rare Diseases.
Goldstein GS
Prog Clin Biol Res; 1985; 197():35-9. PubMed ID: 4070297
[No Abstract] [Full Text] [Related]
18. Rare diseases, orphan drugs, and orphaned patients.
Scheindlin S
Mol Interv; 2006 Aug; 6(4):186-91. PubMed ID: 16960139
[No Abstract] [Full Text] [Related]
19. The Orphan Drug Act: an engine of innovation? At what cost?
Rohde DD
Food Drug Law J; 2000; 55(1):125-43. PubMed ID: 12322720
[No Abstract] [Full Text] [Related]
20. Rare diseases: identifying needs. Report of the National Commission on Orphan Diseases.
Groft SC
Am Pharm; 1990 Apr; NS30(4):33-40. PubMed ID: 2321528
[No Abstract] [Full Text] [Related]
[Next] [New Search]
